Addressing the Emerging Drug Threat of Fentanyl Adulterated or Associated with Xylazine via Harm Reduction and Clinical Innovation
Back to course
Video Transcription
Video Summary
Keywords
Veterans Affairs
opioid crisis
fentanyl
xylosine
overdose rates
harm reduction
naloxone distribution
substance use disorders
holistic care
syringe service programs
addiction treatment
veteran health
AAAP conference
xylazine
emerging drug trends
clinical innovations
Dr. Adam Gordon
Grant Baldwin
CDC
Dr. Joseph Liberto
VA
Elizabeth Oliva
naloxone
veterans
 
American Academy of Addiction Psychiatry
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.


 
400 Massasoit Avenue
Suite 108
East Providence, RI 02914
cmecpd@aaap.org



About
Advocacy
Membership
Fellowship
Education and Resources
Training Events

 
Powered By